Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)
Financial Results:
Alkem Laboratories Ltd reported Revenues for Q3FY25 of ₹3,374.00 Crores up from ₹3,324.00 Crore year on year, a rise of 1.5%.
Total Expenses for Q3FY25 of ₹2,736.00 Crores up from ₹2,711.00 Crores year on year, a rise of 0.92%.
Consolidated Net Profit of ₹641.00 Crores up 6.13% from ₹604.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹52.34, up 5.18% from ₹49.76 in the same quarter of the previous year.
![](data:image/svg+xml;charset=utf-8,<svg height="781px" width="640px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
